Harmen Beurmanjer

111 References Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012). Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors , Vol. 37, pp. 11–24. https://doi.org/10.1016/j.addbeh.2011.09.010 Kleinman, A. (1978). What Kind of Model for the Anthropology of Medical Systems? American Anthropologist , 80 (3), 661–665. https://doi.org/10.1525/aa.1978.80.3.02a00170 KLEINMAN, A. (1978). Culture, Illness, and Care. Annals of Internal Medicine , 88 (2), 251. https://doi.org/10.7326/0003- 4819-88-2-251 Kleinman, A., & Benson, P. (2006). Anthropology in the clinic: The problem of cultural competency and how to fix it. PLoS Medicine , Vol. 3, pp. 1673–1676. https://doi.org/10.1371/journal.pmed.0030294 Klis, S., Vingerhoets, A. J., deWit, M., Zandbelt, N., Snoek, F. J., Cassell, E., …Tellegen, A. (2008). Pictorial Representation of Illness and Self Measure Revised II (PRISM-RII) – a novel method to assess perceived burden of illness in diabetes patients. Health and Quality of Life Outcomes , 6 (1), 104. https://doi.org/10.1186/1477-7525-6-104 Koekkoek, B., Hutschemaekers, G., van Meijel, B., & Schene, A. (2011). How do patients come to be seen as “difficult”?: A mixed-methods study in community mental health care. Social Science and Medicine . https://doi. org/10.1016/j.socscimed.2010.11.036 Koob, G. F. (2006). The neurobiology of addiction: A neuroadaptational view relevant for diagnosis. Addiction , Vol. 101, pp. 23–30. https://doi.org/10.1111/j.1360-0443.2006.01586.x Koob, G. F. (2013). Addiction is a reward deficit and stress surfeit disorder. Frontiers in Psychiatry . https://doi. org/10.3389/fpsyt.2013.00072 Koob, G. F., & Simon, E. J. (2009). The neurobiology of addiction: Where we have been and where we are going. Journal of Drug Issues , 39 (1), 115–132. https://doi.org/10.1177/002204260903900110 Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: a neurocircuitry analysis. The Lancet Psychiatry , Vol. 3, pp. 760–773. https://doi.org/10.1016/S2215-0366 (16)00104-8 Korf, D. J., Nabben, T., Benschop, A., Ribbink, K., & Van Amsterdam, J. G. C. (2014). Risk factors of γ-Hydroxybutyrate Overdosing. European Addiction Research . https://doi.org/10.1159/000353237 Krul, J., & Girbes, A. R. J. (2011). Gamma-hydroxybutyrate: Experience of 9 years of gamma-hydroxybutyrate (GHB)-related incidents during rave parties in The Netherlands. Clinical Toxicology , 49 (4), 311–315. https://doi.or g/10.3109/15563650.2011.576253 Kwako, L. E., & Koob, G. F. (2017). Neuroclinical Framework for the Role of Stress in Addiction. Chronic Stress , 1 , 247054701769814. https://doi.org/10.1177/2470547017698140 Laborit, H. (1964). Sodium 4-hydroxybutyrate. International Journal of Neuropharmacology , 3 (4), 433-IN8. https://doi. org/10.1016/0028-3908(64)90074-7 Leventhal, H, Meyer, D., & Nerenz, D. (1980). The common sense model of illness danger. Medical Psychology , 7–30. Leventhal, Howard, Phillips, L. A., & Burns, E. (2016). The Common-Sense Model of Self-Regulation (CSM): a dynamic framework for understanding illness self-management. Journal of Behavioral Medicine , 39 (6), 935–946. https:// doi.org/10.1007/s10865-016-9782-2 Lingenhoehl, K., Brom, R., Heid, J., Beck, P., Froestl, W., Kaupmann, K., …Mosbacher, J. (1999). γ-Hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. Neuropharmacology , 38 (11), 1667–1673. https://doi. org/10.1016/S0028-3908(99)00131-8 Lingford-Hughes, A., Patel, Y., Bowden-Jones, O., Crawford, M. J., Dargan, P. I., Gordon, F., … Wood, D. M. (2016). Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial. Trials , 17 (1), 472. https://doi.org/10.1186/s13063-016-1593-9 Lorenz-Guertin, J. M., Bambino, M. J., Das, S., Weintraub, S. T., & Jacob, T. C. (2019). Diazepam Accelerates GABAAR Synaptic Exchange and Alters Intracellular Trafficking. Frontiers in Cellular Neuroscience , 13 . https://doi. org/10.3389/fncel.2019.00163 Loughead, J., Wileyto, E. P., Ruparel, K., Falcone, M., Hopson, R., Gur, R., & Lerman, C. (2015). Working Memory-Related Neural Activity Predicts Future Smoking Relapse. Neuropsychopharmacology . https://doi.org/10.1038/ npp.2014.318 Ma, B., Mei, D., Wang, F., Liu, Y., & Zhou, W. (2019). Cognitive enhancers as a treatment for heroin relapse and addiction. Pharmacological Research , Vol. 141, pp. 378–383. https://doi.org/10.1016/j.phrs.2019.01.025 Mason, P. E., & Kerns, W. P. (2002). Gamma hydroxybutyric acid (GHB) intoxication. Academic EmergencyMedicine , 9 (7), 730–739. https://doi.org/10.1197/aemj.9.7.730